CVE-2022-1067 — MEDIUM (6.5)

Q: What is CVE-2022-1067?

CVE-2022-1067 is a vulnerability with a CVSS score of 6.5 (MEDIUM). Navigating to a specific URL with a patient ID number will result in the server generating a PDF of a lab report without authentication and rate limiting.

Q: How severe is CVE-2022-1067?

CVE-2022-1067 has been rated MEDIUM with a CVSS base score of 6.5/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2022-1067?

Check the references section above for vendor advisories and patch information. Affected products include: Lifepoint Patient Portal.

Vulnerability Description

Navigating to a specific URL with a patient ID number will result in the server generating a PDF of a lab report without authentication and rate limiting.

CVSS Score

6.5

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality

HIGH

Integrity

NONE

Availability

NONE

Affected Products

Vendor	Product	Versions
Lifepoint	Patient Portal	< lpi_3.5.12.p30

Related Weaknesses (CWE)

CWE-287 CWE-288

References

https://www.cisa.gov/uscert/ics/advisories/icsma-22-095-01Third Party AdvisoryUS Government Resource
https://www.cisa.gov/uscert/ics/advisories/icsma-22-095-01Third Party AdvisoryUS Government Resource

FAQ

What is CVE-2022-1067?

CVE-2022-1067 is a vulnerability with a CVSS score of 6.5 (MEDIUM). Navigating to a specific URL with a patient ID number will result in the server generating a PDF of a lab report without authentication and rate limiting.

How severe is CVE-2022-1067?

CVE-2022-1067 has been rated MEDIUM with a CVSS base score of 6.5/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-1067?

Check the references section above for vendor advisories and patch information. Affected products include: Lifepoint Patient Portal.